MSB 2.29% $1.07 mesoblast limited

He said on the conference call that FDA wasn't going to consider...

  1. 5,365 Posts.
    lightbulb Created with Sketch. 1962
    He said on the conference call that FDA wasn't going to consider results of any new trials until the potency assays were acceptable and now that hurdle has been achieved, making the next trial possible

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.025(2.29%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.10 $1.13 $1.05 $8.152M 7.517M

Buyers (Bids)

No. Vol. Price($)
6 69963 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 73154 3
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
$1.07
  Change
-0.025 ( 2.84 %)
Open High Low Volume
$1.09 $1.13 $1.05 1873215
Last updated 15.59pm 10/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.